{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:50:38Z","timestamp":1783032638272,"version":"3.54.6"},"posted":{"date-parts":[[2024,4,11]]},"group-title":"In Review","reference-count":19,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,3,25]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold>: Mucociliary clearance plays a critical role in pulmonary host defense. Abnormal mucociliary clearance contributes to the pathogenesis of pulmonary disorders, including COPD. In bronchiectasis, treatments targeting mucus obstruction in the airways include the use of high frequency chest wall oscillation (HFCWO) therapy. This prospective outcome based study was designed to investigate the changes in symptoms and quality of life (QOL) to measure the effect of adjunctive HFCWO therapy to standard of care therapy for patients with COPD.\n<bold>Research Question: <\/bold>When HFCWO is indicated and used as intended, will the quality of life for those patients with COPD improve and sustain improvement.\n<bold>Study Design and Methods<\/bold>: We conducted a prospective, openl-label, observational study in COPD patients without concomitant bronchiectasis. Participants had assessments of QOL at baseline (day 0) and then at 30 and 90 days after initiation of HFCWO therapy. The St. George\u2019s Respiratory Questionnaire for COPD Patients (SGRQ-C) was employed and longitudinally followed at each timepoint. Paired t-tests were used to compare means between each time points adjusted for multiple comparisons. A linear mixed model for the analysis of longitudinal data was then constructed to determine the simultaneous contribution of race, gender, ethnicity, time, and selected interactions in the primary outcome of change in SGRQ-C across 0, 30, and 90 days .\n<bold>Results<\/bold>: The cohort of patients (n=102) demonstrated a significant reduction in the SGRQ-C at 30 and sustained at 90 days compared to baseline. In addition, two component scores of the SGRQ-C questionnaire (\u201cSymptoms\u201d and Impacts\u201d) were significantly reduced at 30 and 90 days.\n<bold>Interpretation<\/bold>: This prospective, observational study demonstrates statistically significant and clinically favorable responses to HFCWO as an adjunctive therapy for patients with a primary diagnosis of COPD without concomitant bronchiectasis. Results of this study inform the design of additional additional studies of HFCWO to prove efficacy inCOPD patients.<\/p>","DOI":"10.21203\/rs.3.rs-4165729\/v1","type":"posted-content","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T15:21:02Z","timestamp":1712848862000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in COPD"],"prefix":"10.21203","author":[{"given":"Meaghan M","family":"Bruner","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Bazan","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cheng","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Chad","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chet","family":"Sievert","sequence":"additional","affiliation":[{"name":"Clinical Research Associates LLC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Edwards","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Solomon","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8761","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1165\/rcmb.2006-0082SF","article-title":"Effective Mucus Clearance Is Essential for Respiratory Health","volume":"35","author":"Randell SH","year":"2006","unstructured":"Randell SH, Boucher RC. Effective Mucus Clearance Is Essential for Respiratory Health. Am J Respir Cell Mol Biol. 2006;35(1):20\u20138. 10.1165\/rcmb.2006-0082SF.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/COPD.S38938","article-title":"Clinical issues of mucus accumulation in COPD","volume":"9","author":"Ramos FL","year":"2014","unstructured":"Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chronic Obstr Pulm Dis. 2014;9:139\u201350. 10.2147\/COPD.S38938.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"116","key":"ref3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1183\/09059180.00002710","article-title":"Revisited role for mucus hypersecretion in the pathogenesis of COPD","volume":"19","author":"Cerveri I","year":"2010","unstructured":"Cerveri I, Brusasco V. Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respiratory Rev. 2010;19(116):109. 10.1183\/09059180.00002710.","journal-title":"Eur Respiratory Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2147\/copd.S22896","article-title":"A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion","volume":"6","author":"Chakravorty I","year":"2011","unstructured":"Chakravorty I, Chahal K, Austin G. A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion. Int J Chron Obstruct Pulmon Dis. 2011;6:693\u20139. 10.2147\/copd.S22896. (In eng).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"ref5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1191\/1479972306cd097rs","article-title":"Is there a role for airway clearance techniques in chronic obstructive pulmonary disease?","volume":"3","author":"Holland AE","year":"2006","unstructured":"Holland AE, Button BM. Is there a role for airway clearance techniques in chronic obstructive pulmonary disease? Chron Respir Dis. 2006;3(2):83\u201391. 10.1191\/1479972306cd097rs. (In eng).","journal-title":"Chron Respir Dis"},{"issue":"8","key":"ref6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1183\/09031936.95.08081333","article-title":"Chronic mucus hypersecretion in COPD and death from pulmonary infection","volume":"8","author":"Prescott E","year":"1995","unstructured":"Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J. 1995;8(8):1333. 10.1183\/09031936.95.08081333.","journal-title":"Eur Respir J"},{"issue":"21","key":"ref7","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2023.2065","article-title":"Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease","volume":"329","author":"Diaz AA","year":"2023","unstructured":"Diaz AA, Orejas JL, Grumley S, et al. Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease. JAMA. 2023;329(21):1832\u20139. 10.1001\/jama.2023.2065.","journal-title":"JAMA"},{"issue":"159","key":"ref8","doi-asserted-by":"publisher","first-page":"200281","DOI":"10.1183\/16000617.0281-2020","article-title":"New bronchoscopic treatment modalities for patients with chronic bronchitis","volume":"30","author":"Hartman JE","year":"2021","unstructured":"Hartman JE, Garner JL, Shah PL, Slebos D-J. New bronchoscopic treatment modalities for patients with chronic bronchitis. Eur Respiratory Rev. 2021;30(159):200281. 10.1183\/16000617.0281-2020.","journal-title":"Eur Respiratory Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1753466620932508","DOI":"10.1177\/1753466620932508","article-title":"Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis","volume":"14","author":"Barto TL","year":"2020","unstructured":"Barto TL, Maselli DJ, Daignault S, et al. Real-life experience with high-frequency chest wall oscillation vest therapy in adults with non-cystic fibrosis bronchiectasis. Ther Adv Respir Dis. 2020;14:1753466620932508. 10.1177\/1753466620932508. (In eng).","journal-title":"Ther Adv Respir Dis"},{"issue":"8","key":"ref10","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/ppul.24784","article-title":"The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance","volume":"55","author":"Leemans G","year":"2020","unstructured":"Leemans G, Belmans D, Van Holsbeke C, et al. The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance. Pediatr Pulmonol. 2020;55(8):1984\u201392. 10.1002\/ppul.24784. (In eng).","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2466-13-21","article-title":"Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis","volume":"13","author":"Nicolini A","year":"2013","unstructured":"Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC Pulm Med. 2013;13(1):21. 10.1186\/1471-2466-13-21.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12890-019-0844-4","article-title":"Employment of an algorithm of care including chest physiotherapy results in reduced hospitalizations and stability of lung function in bronchiectasis","volume":"19","author":"Powner J","year":"2019","unstructured":"Powner J, Nesmith A, Kirkpatrick DP, Nichols JK, Bermingham B, Solomon GM. Employment of an algorithm of care including chest physiotherapy results in reduced hospitalizations and stability of lung function in bronchiectasis. BMC Pulm Med. 2019;19(1):82. 10.1186\/s12890-019-0844-4. (In eng).","journal-title":"BMC Pulm Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1081\/COPD-200050513","author":"Jones PW","year":"2005","unstructured":"Jones PW. St. George's Respiratory Questionnaire: MCID. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2005;2(1):75\u201379. 10.1081\/COPD-200050513."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jclinepi.2019.07.015","article-title":"Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study","volume":"116","author":"Alma H","year":"2019","unstructured":"Alma H, de Jong C, Jelusic D, et al. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study. J Clin Epidemiol. 2019;116:49\u201361. 10.1016\/j.jclinepi.2019.07.015. (In eng).","journal-title":"J Clin Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/copd.S181246","article-title":"Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis","volume":"13","author":"Cui Y","year":"2018","unstructured":"Cui Y, Luo L, Li C, Chen P, Chen Y. Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:3813\u201329. 10.2147\/copd.S181246. (In eng).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"ref16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for Prevention of Exacerbations of COPD","volume":"365","author":"Albert RK","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, et al. Azithromycin for Prevention of Exacerbations of COPD. N Engl J Med. 2011;365(8):689\u201398. 10.1056\/NEJMoa1104623.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/01926230601060025","article-title":"Cystic fibrosis and other respiratory diseases of impaired mucus clearance","volume":"35","author":"Livraghi A","year":"2007","unstructured":"Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol. 2007;35(1):116\u201329. 10.1080\/01926230601060025. (In eng).","journal-title":"Toxicol Pathol"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"1900419","DOI":"10.1183\/13993003.00419-2019","article-title":"Excess mucus viscosity and airway dehydration impact COPD airway clearance","volume":"55","author":"Lin VY","year":"2020","unstructured":"Lin VY, Kaza N, Birket SE, et al. Excess mucus viscosity and airway dehydration impact COPD airway clearance. Eur Respir J. 2020;55(1):1900419. 10.1183\/13993003.00419-2019.","journal-title":"Eur Respir J"},{"issue":"2","key":"ref19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1183\/09031936.00163607","article-title":"Health-related quality of life in COPD patients with chronic respiratory failure","volume":"32","author":"Duiverman ML","year":"2008","unstructured":"Duiverman ML, Wempe JB, Bladder G, Kerstjens HAM, Wijkstra PJ. Health-related quality of life in COPD patients with chronic respiratory failure. Eur Respir J. 2008;32(2):379. 10.1183\/09031936.00163607.","journal-title":"Eur Respir J"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4165729\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4165729\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T13:45:02Z","timestamp":1715089502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4165729\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4165729\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,4,11]]},"subtype":"preprint"}}